EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Tretinoin/isotretinoin interconversion A problem in preparing pharmaceutical formulations



Tretinoin/isotretinoin interconversion A problem in preparing pharmaceutical formulations



Acta Farmaceutica Bonaerense 22(3): 249-254, Julio-Septiembre



Tretinoin is applied topically in the treatment of acne. Isotretinoin, its isomer, inhibits keratinization and it is used orally. Both are light sensitive. The aim of the present work is to evaluate the purity of tretinoin (raw material) used in local pharmacies for pharmaceutical preparations. Analysis was carried out according to official codes. Tretinoin sample was found to be out of pharmacopeial specifications. Methanolic solutions of both isomers were also analysed by HPLC, in order to evaluate their photostability. After 25 minutes less than 30% of original substance remained in the solutions. Tretinoin is the main degradation product of isotretinoin and vice-versa.

(PDF 0-2 workdays service: $29.90)

Accession: 035985764

Download citation: RISBibTeXText



Related references

UVA is the major contributor to the photodegradation of tretinoin and isotretinoin: Implications for development of improved pharmaceutical formulations. International Journal of Pharmaceutics 352(1-2): 123-128, 2007

Accelerated photostability study of tretinoin and isotretinoin in liposome formulations. International Journal of Pharmaceutics 293(1-2): 251-260, 2005

A rapid HPLC method for simultaneous determination of tretinoin and isotretinoin in dermatological formulations. Journal of Pharmaceutical and Biomedical Analysis 43(3): 859-864, 2006

A specific and sensitive HPLC-UV assay for the determination of tretinoin and isotretinoin for dermatopharmacokinetic evaluation of tretinoin cream. Pharmaceutical Research (New York) 14(11 SUPPL ): S565-S566, 1997

Simultaneous determination of minoxidil and tretinoin in pharmaceutical and cosmetic formulations by reversed phase hplc. Analytical Letters 24(10): 1825-1836, 1991

Chiral HPLC analysis of formoterol stereoisomers and thermodynamic study of their interconversion in aqueous pharmaceutical formulations. Journal of Pharmaceutical and Biomedical Analysis 49(3): 632-637, 2009

Process for preparing pharmaceutical compositions for use with soft gelatin formulations. Official Gazette of the United States Patent & Trademark Office Patents 1258(2), May 14, 2002

Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same. Official Gazette of the United States Patent & Trademark Office Patents 1246(2), May 8, 2001

Isotretinoin conundrum: a randomized, openlabel, crossover study in Mexico to evaluate the bioavailability and bioequivalence of three pharmaceutical preparations of isotretinoin in healthy participants. International Journal of Clinical Pharmacology and Therapeutics 53(10): 897-904, 2015

Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith. Official Gazette of the United States Patent & Trademark Office Patents 1284(3), July 20, 2004

In vitro percutaneous absorption of isotretinoin and its isomerization to tretinoin. Clinical Research 36(3): 667A, 1988

Epidermal effects of tretinoin and isotretinoin: influence of isomerism. Die Pharmazie 61(5): 453-456, 2006

Method of preparing controlled long acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics us patent 4775535 october 4 1988. 1988

Method of preparing controlled long acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics us patent 4855143 august 8 1989. Official Gazette of the United States Patent & Trademark Office Patents 1105(2): 1040, 1989

Low dose isotretinoin combined with tretinoin is effective to correct abnormalities of acne. Journal der Deutschen Dermatologischen Gesellschaft 2(1): 31-45, 2005